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Deletion mutants of the Ca*+ ATPase of rabbit fast-twitch skeletal muscle sarcoplasmic reticulum (SERCAla) were constructed and expressed in 
COS-1 cells. The mutants were expressed at levels 7-to 15-fold lower than the wild-type and were inactive. In vitro transcription-translation-insertion 
experiments howed that deletion of transmembrane s quences M, and M,, but not of M,, M,, M,, or the NH,-terminal 30 amino acids inhibited 
the stable insertion of the enzyme into the membrane. Thus there was no correlation between loss of function and membrane insertion. A signal 
sequence for membrane insertion may exist in M, and M,. 
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1. INTRODUCTION 
The Ca2+ ATPase of sarcoplasmic reticulum is a 
membrane protein of molecular weight 110,000 [1,2]. 
Primary sequence analysis [2,3] predicts a headpiece, 
stalk and basepiece structure with ten transmembrane 
helices. The Ca2’ ATPase has been expressed in COS-1 
cells [4] and some 250 mutants have been examined for 
Ca2+ transport activity and for their ability to form 
phosphoenzyme intermediates [5,6]. While 200 of these 
amino acid substitutions have not resulted in any signif- 
icant alteration of function, non-functional mutations 
have been categorized as defective in phosphorylation, 
Ca2’ binding, ATP binding, or conformational changes 
[6]. The first of these critical amino acid was found at 
position 111 and the last at position 908, out of 994 
amino acids. Of the non critical residues studied, 24 
were located upstream of amino acid 111 in the first 
transmembrane loop and 12 were located downstream 
of amino acid 908 in the last transmembrane loop. Ac- 
cordingly, NH,- or COOH-terminal segments would 
not appear to be required for the production of a func- 
tional protein. To test this possibility, we have con- 
structed deletion mutants at the NH,- and COOH-ter- 
mini and measured their enzymatic activity, when ex- 
pressed in COS- 1 cells. We also performed in vitro tran- 
scription-translation-insertion experiments on the mu- 
tants to examine whether the loss of function we ob- 
served in these deletion mutants was related to their 
ability to insert into microsomes. 
2. EXPERIMENTAL 
2.1. Construction of deletion mutants 
An NcoI site was inserted at the initiator methionine in rabbit 
fast-twitch Ca2’ ATPase cDNA [3] by site-directed mutagenesis. Mu- 
tant 1 was constructed by removal of an NcoI-X&I restriction endo- 
nuclease fragment, filling in with Klenow fragment and blunt end 
ligation. The amino acid sequence at the juncture was Met-Leu-Glu- 
with removal of cytoplasmic residues 2-32 (Fig. 1). Mutant 2 was 
constructed by similar removal of an XbaI-BglI fragment, resulting 
in removal of residues 34-l 16 comprising predicted transmembrane 
sequences M, and M,. Mutant 3 was constructed by deletion of a BgAI 
fragment, followed by religation, resulting in removal of residues 891- 
973 comprising predicted transmembrane sequences M,, M, and part 
of M,,. Mutant 4 was constructed by blunt end ligation of the cDNA 
which had been digested with BstEll and filled in by treatment with 
Klenow fragment. This resulted in the generation of a TGA stop 
codon following residue Thrm and removal of residues 9077994 com- 
prising part of predicted transmembrane sequence M, and all of Mg 
and M,,. Mutant 5 was constructed using mutagenesis [7] to convert 
the codon encoding LysW to a TAA stop codon, thereby deleting 
predicted transmembrane sequence M,,. Mutant 6 was constructed 
using mutagenesis to convert the codon encoding Met9r5 to a TAG 
stop codon, thereby deleting predicted transmembrane s quences M, 
and M,,. 
*Corresponding author. Fax: (1) (416) 978 8528. 
**Present address: Department of Medicine, University of Ottawa, 
451 Smyth Road, Ottawa, Ontario KlH 8M5, Canada. 
***Present address: Department of Medicine, University of Toronto, 
Medical Sciences Building, Toronto, Ontario M5S lA1, Canada. 
The wild type and mutant Ca2’ ATPase cDNAs were cloned into 
the EcoRI site of vector p91023(B) [8] for expression in COS-1 cells 
[18], microsomes were prepared from transfected cells and measure- 
ment of Ca” transport and phosphoenzyme formation were carried 
out as described previously [4,9,10]. A sandwich enzyme-linked im- 
munosorbent assay was used to quantify the expressed Ca2’ ATPase 
[ll], using monoclonal antibody A52 [12]. 
Ca2’ ATPase was solubilized from 100 fig of microsomal protein in 
C,,E,/asolectin (2:l) at a ratio of total protein/C,,E, of 5:l and im- 
munopurified with A-52 monoclonal antibody (200 ~1 final volume), 
as described previously [13]. The Ca2’ ATPase-A52-Protein A- 
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Sepharose complex was used ~mediately for m~su~ment of 
phosphoenzyme formation [13]. 
For in vitro transcription-translation-insertion experiments, site- 
directed mutagenesis was used to insert a NheI site immediately after 
the stop codon of Ca” ATPase and NheI linkers were blunt end ligated 
into the NceI site at the initiator methionine. The wild type and mutant 
cDNAs were digested with NheI and cloned into the X&I site of the 
plasmid pSP65 (Promega Corporation, Madison WI). This procedure, 
which effectively removed all of the untranslated 5’ and 3’ regions of 
the cDNA, was found to be essential for efficient translation. The 
constructs were linearized with Hind111 and transcribed as described 
by Melton et al. [14]. The RNA was translated in rabbit reticulocyte 
lysate with [35Shnethionine i  the presence and absence of dog pancre- 
atic microsomes, following the protocols from Promega (Translation 
in vitro, Twhnical Manual). 
3. RESULTS 
3.1. Construction, expression and assay of deletion mu- 
tants 
Ca*’ ATPase mutations consisting of deletions to ei- 
ther the extreme NH,-terminus (mutant l), the first two 
membrane spanning domains (mutant 2), or various 
membrane spanning domains at the COOH-terminus 
(mutants 3-6) were constructed as outlined in Fig. 1. 
I~unoblot analysis of ~crosomal proteins from 
transfected COS-1 cells showed a significant reduction 
in expression of the deletion mutants, compared to wild 
type protein and, in some mutants, ‘ladder’ formation 
indicating degradation of the expressed protein (Fig. 2). 
Quantitation of Ca*’ ATPase by a sandwich ELISA [ 1 l] 
showed that the deletion mutants were expressed at lev- 
els 7- to 15”fold lower than wild type. 
Because of the low expression of the deletion mutants 
and the relatively high endogenous Ca*’ ATPase levels 
in COS-1 cells, it was difficult to measure enzymatic 
activity without purifying the expressed protein. We 
have purified it from C,,E, extracts of microsomes by 
interaction with the A52 monoclonal antibody bound 
to protein A Sepharose under conditions where at least 
50% of wild type ATPase activity is retained [13]. Dele- 
tion mutants purified in this manner were not 
Deletion Mutants of Cz+AfPase 
12 34 56 7 8910 
wt L ID Di 
t) A 2-32 J-m 
2) A 34-116 U-m 
3) A 691.973 r-v 
4) A 906.994 I# 
5) A 961-994 rum 
6) A 925-994 In 
Fig. 1. Construction of deletion mutants of the Ca*’ ATPase. The wild 
type enzyme (Wt) is depicted as a bar, with the ten transmembrane 
domains shown as black rectangles and labeled I-10. The deleted 
amino acids are listed beside each construct, labeled 1-6, and are 
depicted in the figure by missing parts of the bar. 
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Fig. 2. Expression of Ca2+ ATPase deletion mutants. Microsomes were 
prepared from COS-1 cells transfected with wild type (WT) and mu- 
tant Ca” ATPases (lanes l-6 for mutants l-6, respectively). Micro- 
somd proteins were separated on 10% SDS-PAGE (-ZO.@lane) and 
i~~oblotted with monoclonal antibody AS2. 
phosphoryiated by either ATP or inorganic phosphate 
(P,), under conditions in which 20-fold less of the wild 
type enzyme produced a strong signal corresponding to 
the phosphoenzyme intermediate band (Fig. 3). Thus 
deletions as small as 30 amino acids from the NH,- 
terminus and 33 amino acids from the COOH-terminus 
destroyed the earliest steps in the reaction cycle of the 
Ca*’ ATPase. 
The deletion mutants may have been inactive and 
expressed at lower levels because they were not inte- 
grated into the membrane in a stable fashion. To exam- 
ine the ability of the various deletion mutants to insert 
into membranes, in vitro transcription-translation-in- 
sertion experiments were performed (Fig. 4). The wild 
type Ca*’ ATPase and mutants 1, 3, 4, 5, and 6 were 
found to integrate into the membrane in a fashion resis- 
tant to extraction with salt or base under conditions 
which normally remove all but integral membrane pro- 
teins [15]. Analysis of autoradiograms by densitometry 
showed that an average of 6-fold more of these proteins 
were pelleted in the presence than in the absence of 
membranes after extraction at pH 11.5 (compare + and 
- microsomes, Fig. 4). By contrast, only an average of 
1.4-fold more of mutant 2 was pelleted under similar 
conditions. Thus, mutant 2, lacking the first two trans- 
membrane domains, was the only mutant which inter- 
acted weakly with the membranes. Those mutants that 
were stably associated with the membrane were, never- 
theless, expressed at low levels in COS-1 cells. 
% Sample 20 10 5 100 
cDNA wildtypeC1 23456 
ATP 
Pi 
Fig. 3. Phosphorylation of wild type and mutant CaZ+ ATPases. Ca*’ 
ATPases were purified and phosphorylated with ATP or inorganic 
phosphate (Pi). Separation of 20, 10, and 5% of the total wild type 
sample and 100% of both mutant (lanes 1-6) and control (C) samples 
was performed on 6% SDS-PAGE in running buffer adjusted to pH 
6.3 [17]. 
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low levels in COS-1 cells? Defects in transcription or 
translation seem unlikely from the in vitro studies. Most 
probably, the cells have a mechanism of detecting en- 
zymes which are structurally defective and of degrading 
them through proteolysis. Enzymes defective only in 
function may escape this surveillance mechanism, since 
many inactive point mutations are expressed normally 
in COS-1 cells [4-6]. It is most likely that the deletion 
mutants do not exist in a native conformation and can 
be recognized by the cell as defective, regardless of their 
transmembrane topology. 
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Fig. 4. In vitro insertion of wild type and mutant Ca” ATPases into 
dog pancreatic microsomes. Wild type and mutant Ca*+ ATPase 
mRNAs were produced by in vitro transcription with Sp6 RNA 
polymerase, and the RNA was translated in vitro with [35S]methionine 
in the presence (+) or absence (-) of dog pancreatic microsomes (M). 
Samples were either untreated or treated with 1 M KC1 or 100 mM 
Na,C09, pH 11.5, for 10 minutes on ice and recovered by centrifuga- 
tion in an airfuge operating at 30 psi for 10 minutes. The pellets were 
separated by 10% SDS-PAGE and subjected to autoradiography. 
4. DISCUSSION 
The deletion of as little as 3% of the amino acid 
sequence of the Ca*’ ATPase from either the NH*- or 
COOH-termini can cause a total loss of enzymatic activ- 
ity. Although there is no indication from site-directed 
mutagenesis that specific residues in these sequences are 
crucial for activity, it is probable that these sequences 
are required to maintain the three-dimensional struc- 
ture of the native protein. Examination of the synthetic 
insertion of the six mutants into membranes showed 
that deletion of the first transmembrane loop prevented 
stable membrane integration, while deletion of the cy- 
tosolic NH,-terminal sequence or of transmembrane se- 
quences M,-M,o had no observable ffect on membrane 
insertion. Although loss of activity of mutant 2 could 
be ascribed to lack of integration into the membrane, 
this could not be true for mutants 1, 3, 4, 5, or 6. 
If five out of the six mutants can be stably integrated 
into the membrane, then why are they all expressed at 
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